Antibody-targeted T cells and natural killer cells for cancer immunotherapy

This research shows the potential for a non-genetic method for redirecting cytotoxic immune cells as a feasible and effective approach for tumor-targeted cell immunotherapy.

Authors

Institutions

Publication Details

Journal
Journal of Nanobiotechnology
Published
2024-10-18
DOI
https://doi.org/10.1186/s12951-024-02898-3
Citations
4
Primary Topic
CAR-T cell therapy research
Type
article
Field-Weighted Citation Impact
1.13
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Antibody-targeted T cells and natural killer cells for cancer immunotherapy

John F. DeCoteau, Ashley R. Sutherland, David Livingstone, Wendy Bernhard et al.
4 citations
Journal of Nanobiotechnology
CAR-T cell therapy research
1.13
article

Antibody-targeted T cells and natural killer cells for cancer immunotherapy

John F. DeCoteau, Ashley R. Sutherland, David Livingstone, Wendy Bernhard, C. Ronald Geyer, Tays Hernández García, Alberto Medina, Brijesh Parlekar
article en
4 citations

Abstract

This research shows the potential for a non-genetic method for redirecting cytotoxic immune cells as a feasible and effective approach for tumor-targeted cell immunotherapy.

Journal of NanobiotechnologyVol. 22(1)
Center of Molecular Immunology (Cuba) (CU), University of Saskatchewan (CA)
Good health and well-being
Openalex Percentile: Top 18%
CAR-T cell therapy research
1.13
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.